This inventor holds 1 USPTO granted patent. Top assignee: Step Pharma S.a.s.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Geraint Jones: Innovator in Pharmaceutical Chemistry
Introduction
Geraint Jones is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of compounds that target critical biological pathways. His work focuses on creating innovative solutions for the treatment of proliferative diseases.
Latest Patents
Geraint Jones holds a patent for N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases. This patent represents a significant advancement in therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
Geraint is currently associated with Step Pharma S.a.s., where he continues to push the boundaries of pharmaceutical research. His work at the company has been instrumental in developing new treatments that have the potential to improve patient outcomes.
Collaborations
Geraint has collaborated with talented individuals such as Abdul Quddus and Andrew Novak. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Geraint Jones is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments for proliferative diseases. His contributions are vital to the ongoing advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile